There is an increasing interest in biomarkers of nitric oxide dysregulation and oxidative
stress to guide management and identify new therapeutic targets in patients with chronic …

Background Alterations in nitric oxide (NO) synthesis have been reported in Alzheimer's
disease and vascular dementia. However, as the measurement of NO in biological samples …

Nitric oxide (NO) is a small molecule involved in the regulation of many physiological
processes. It plays a crucial role in the regulation of nervous system, immune and …

Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is a key enzyme involved in
the metabolism of the endogenous nitric oxide synthase (NOS) inhibitors asymmetric …

Background Changes in NO metabolism correlate with cardiovascular risk factors and are
associated with endothelial dysfunction. NO availability is regulated by nitric oxide synthase …

Background and aims The effects of low dose prednisolone on circulating markers of
endothelial function, the arginine metabolites asymmetric dimethyl arginine (ADMA), mono …

Nitric oxide (NO) is a regulatory molecule involved in many biological processes. NO is
produced by nitric oxide synthase by conversion of l‐arginine to l‐citrulline. l‐Arginine …

Alterations of nitric oxide (NO) homeostasis have been described in mood disorders.
However, the analytical challenges associated with the direct measurement of NO have …

Dimethylarginine dimethylaminohydrolase (DDAH) is a key enzyme involved in the
metabolism of asymmetric dimethylarginine (ADMA) and N-monomethyl arginine (NMMA) …

Metabolomics, also referred to as metabonomics, is one of the most recent innovative
technologies in medicine. It offers a direct functional read-out of phenotypes by the …